Author:
Liner Kevin J.,Ro Michelle J.,Robertson Kevin R.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference56 articles.
1. Antinori A, Arendt G, Becker JT, et al.: Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789–1799.
2. Robertson KR, Smurzynski M, Parsons TD, et al.: The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007, 21:1915–1921.
3. •• Ellis R: Effects of CNS antiretroviral distribution on neurocognitive impairment in the AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) Study. In 134th Annual Meeting of the American Neurolological Association. Baltimore, MD; October 11–14, 2009. The ACTG ALLRT study yields evidence that higher-ranking CPE regimens correlate with neurocognitive improvement.
4. Sterne JA, May M, Costagliola D, et al.: Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009, 373:1352–1363.
5. Tozzi V, Balestra P, Salvatori MF, et al.: Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr 2009, 52:56–63.
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献